Familial risk of venous thromboembolism: A nationwide cohort study

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 2, 2011, Pages 320-324

  Sorensen H T ^a   Riis, A H ^a   Diaz, L J ^b   Andersen, E W ^b   Baron, J A ^c,d   Andersen, P K ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cohort study; Epidemiology; Familial risk; Venous thromboembolism

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; DENMARK; FAMILIAL INCIDENCE; FEMALE; GENETIC RISK; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO;

ADULT; COHORT STUDIES; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; VENOUS THROMBOEMBOLISM;

EID: 79251558446     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.04129.x     Document Type: Article

References (39)

1. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 2003; 25: 1-5.
2. Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 2006; 21: 23-9.
3. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163-74.
4. Goldhaber SZ. Pulmonary embolism. Lancet 2004; 363: 1295-305.
5. Rosendaal FR, Reitsma PH. Genetics of venous thrombosis. J Thromb Haemost 2009; 7(Suppl. 1): 301-4.
6. Egeberg O. Inherited fibrinogen abnormality causing thrombophilia. Thromb Diath Haemorrh 1967; 17: 176-87.
7. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K, Lumley T, Bis JC, Wiggins KL, Rosendaal FR, Psaty BM. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 2007; 297: 489-98.
8. Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT, Bass EB. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 2009; 301: 2472-85.
9. Brouwer JL, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med 2006; 145: 807-15.
10. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293: 2352-61.
11. Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 2009; 169: 610-15.
12. Briët E, van der Meer FJM, Rosendaal FR, Houwing-Duistermaat JJ, van Houwelingen HC. The family history and inherited thrombophilia. Br J Haematol 1994; 87: 348-52.
13. Cosmi B, Legnani C, Bernardi F, Coccheri S, Palareti G. Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study. BMJ 2001; 322: 1024-5.
14. Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR. Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thromb Haemost 2000; 83: 817-21.
15. Aznar J, Mira Y, Vaya A, Ferrando F, Villa P. Is family history sufficient to identify women with risk of venous thromboembolism before commencing the contraceptive pill? Clin Appl Thromb Hemost 2002; 8: 139-41.
16. Caprini JA, Goldshteyn S, Glase CJ, Hathaway K. Thrombophilia testing in patients with venous thrombosis. Eur J Vasc Endovasc Surg 2005; 30: 550-5.
17. van Sluis GL, Söhne M, El Kheir DY, Tanck MW, Gerdes VEA, Büller HR. Family history and inherited thrombophilia. J Thromb Haemost 2006; 4: 2182-7.
18. Hron G, Eichinger S, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Stain M, Gartner V, Kyrle PA. Family history for venous thromboembolism and the risk for recurrence. Am J Med 2006; 119: 50-3.
19. Sørensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.
20. Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370: 1773-9.
21. Gaist D, Vaeth M, Tsiropoulos I, Christensen K, Corder E, Olsen J, Sørensen HT. Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in Denmark. BMJ 2000; 320: 141-5.
22. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53: 441-9.
23. Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287: 2398-9.
24. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke and venous thromboembolism. Am J Epidemiol 2005; 162: 975-82.
25. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford: Oxford University Press, 1996.
26. Larsen TB, Sørensen HT, Skytthe A, Johnsen SP, Vaupel JW, Christensen K. Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology 2003; 14: 328-32.
27. Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001; 10: 733-41.
28. Wilson BJ, Qureshi N, Santaguida P, Little J, Carroll JC, Allanson J, Raina P. Systematic review: family history in risk assessment for common diseases. Ann Intern Med 2009; 151: 878-85.
29. Khoury MJ, Beaty TH, Liang K-Y. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol 1988; 127: 674-83.
30. Peto J. Genetic predisposition to cancer. In: Cairns J, Lyon JL, Skolnick M, eds. Banbury Report 4: Cancer Incidence in Defined Populations. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1980: 203-13.
31. Weiss KM, Chakraborty R, Majumder PP. Problems in the assessment of relative risk of chronic disease among biological relatives of affected individuals. J Chronic Dis 1982; 35: 539-51.
32. Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, Rosendaal FR. Gene variants associated with deep vein thrombosis. JAMA 2008; 299: 1306-14.
33. Cushman M. Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program 2005; 452-7.
34. Stunkard AJ, Sørensen TI, Hanis C, Teasdale TW, Chakraborty R, Schull WJ, Schulsinger F. An adoption study of human obesity. N Engl J Med 1986; 314: 193-8.
35. Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of anticoagulation trial. N Engl J Med 2000; 342: 1953-8.
36. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-6.
37. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjønneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 2010; 63: 223-8.
38. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107(23 Suppl. 1): I4-8.
39. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-8.